Clinical trial
Application of Rapid Detection of Exhaled Volatile Organic Compounds in the Emergency Department for Differentiating High-Risk Chest Pain Patients
NCT07379567 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Rapid Detection of Exhaled Volatile Organic Compounds in the Emergency Department for Differentiating High-Risk Chest Pain Patients
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 6,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, high-risk chest pain, volatile organic compounds